1. The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage
- Author
-
Pilar Ciruela, Conchita Izquierdo, Sonia Broner, Carmen Muñoz-Almagro, Sergi Hernández, Carmen Ardanuy, Roman Pallarés, Angela Domínguez, Mireia Jané, Cristina Esteva, Mariona Fernández de Sevilla, Desiree Henares, Immaculada Grau, Francesc Marco, Jaume Llaberia, Araceli González-Cuevas, Alvaro Díaz, Maria Teresa Martin, Montserrat Sierra, Margarida Curriu, Carme Gallés, Pilar Hernández, Paula Gassiot, Matilde Martínez-Zurita, Carmina Martí, Montserrat Morta, Goretti Sauca, Asunción Gassós, Esther Sanfeliu, Frederic Ballester, Isabel Pujol, Montserrat Olsina, Xavier Raga, Frederic Gómez-Bertomeu, Mar Olga Pérez-Moreno, Anna Vilamala, Marian Navarro, Mercè Ribelles, Eduardo Padilla, Nuria Prim, Dionisia Fontanals, Miguel Angel Benítez, Eulalia Jou, Carmina Sanjosé, Montserrat Giménez, Maria Dolores Quesada, Jose Carlos de la Fuente, Ana Calderon, Percy Juan Ayala, Laia Vega, Josefa Pérez-Jové, Conchita Balado, and Ines Valle
- Subjects
Adult ,Male ,0301 basic medicine ,Serotype ,Pediatrics ,medicine.medical_specialty ,Vaccination Coverage ,Adolescent ,030106 microbiology ,Serogroup ,medicine.disease_cause ,Pneumococcal Infections ,Pneumococcal conjugate vaccine ,Herd immunity ,Pneumococcal Vaccines ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Streptococcus pneumoniae ,Epidemiology ,Humans ,Medicine ,030212 general & internal medicine ,Child ,Aged ,Aged, 80 and over ,General Veterinary ,General Immunology and Microbiology ,business.industry ,Incidence ,Incidence (epidemiology) ,Infant, Newborn ,Public Health, Environmental and Occupational Health ,Infant ,Middle Aged ,medicine.disease ,Vaccination ,Pneumonia ,Infectious Diseases ,Spain ,Child, Preschool ,Molecular Medicine ,Female ,business ,medicine.drug - Abstract
BACKGROUND We studied the impact of 13-valent pneumococcal conjugate vaccine (PCV13) on the incidence of invasive pneumococcal disease (IPD) and serotype distribution in a region with intermediate levels of vaccination (around 64% in children aged
- Published
- 2018
- Full Text
- View/download PDF